BioWorld MedTech

Sep. 3, 2010

Spine market facing growth challenges, analyst says

Right now it's better to be a smaller, well-capitalized spine company with a broad product line than a larger spine company, according to one analyst who covers the space. (Medical Device Daily) Read More

Study shows Cepheid's test is an 'Xpert' in diagnosing TB

SYNTAX creates common ground for coronary risk assessment

Washington roundup: Alphatec warned after taking back some manufacturing work

Holiday notice

Med-Tech Notes

Deals roundup: Erba buys most of Ivax shares for $15M

MDD's food for med-tech thought

Agreements/contracts: LifeCell to distribute Novadaq's SPY imaging

Courts report: Allergan to pay $600M to settle Botox-related charges

Financings roundup: AHP discloses results of self-tender offer

Restructuring roundup: Angeion restructures board and names two new officers

People in the News

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for July 24, 2026.

To viral or not to viral: In vivo CAR T debates delivery tech

BioWorld

The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 21, 2026

Tree in the shape of human head losing leaves

KBN-2201 reverses key features of Alzheimer’s in mice

BioWorld Science

Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.

Click chemistry drug bound to pancreatic cancer cells from mice

In vivo click ADCs could address tumor heterogeneity

BioWorld

Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...